http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109021020-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da2f79017444789d747982d4ab13b908
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28dc333ead6d4ba495c6e3f866c18b02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e24f703c3d66324011338830757967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664e419c24c2bd48a8f71176a21544a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67c55c63ecabfe72e4c683c78f43f7f
publicationDate 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109021020-A
titleOfInvention 11,12-Dimethylbenzimidazole-1,8-naphthalimide-platinum complex and its preparation method and application
abstract The invention discloses a 11,12-dimethylbenzimidazole-1,8-naphthalimide-platinum complex, a preparation method and an application thereof. The preparation method of the complex mainly includes the following steps: take the compound shown in the following formula (II) and the compound shown in formula (III) in an organic solvent, and carry out a coordination reaction under heating or without heating to obtain the target product. The inhibitory activity of the complex of the present invention on certain cancer cells is significantly higher than that of cisplatin, a commonly used anti-tumor drug, and its toxicity to normal human liver cells HL-7702 is lower. The structure of the complex of the present invention is shown in the following formula (I), and the structures of the compound shown in the raw material formula (II) and the compound shown in formula (III) involved in the preparation of the complex are as follows:
priorityDate 2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007006019-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107746418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016028225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104447876-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009110000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016067241-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414101950

Total number of triples: 25.